Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations

An international study

L. Faivre, G. Collod-Beroud, B. L. Loeys, A. Child, C. Binquet, E. Gautier, B. Callewaert, E. Arbustini, K. Mayer, M. Arslan-Kirchner, A. Kiotsekoglou, P. Comeglio, N. Marziliano, Harry C Dietz, D. Halliday, C. Beroud, C. Bonithon-Kopp, M. Claustres, C. Muti, H. Plauchu & 12 others P. N. Robinson, L. C. Adès, A. Biggin, B. Benetts, M. Brett, K. J. Holman, J. De Backer, P. Coucke, U. Francke, A. De Paepe, G. Jondeau, C. Boileau

Research output: Contribution to journalArticle

Abstract

Mutations in the fibrillin-1 (FBN1) gene cause Marfan syndrome (MFS) and have been associated with a wide range of overlapping phenotypes. Clinical care is complicated by variable age at onset and the wide range of severity of aortic features. The factors that modulate phenotypical severity, both among and within families, remain to be determined. The availability of international FBN1 mutation Universal Mutation Database (UMD-FBN1) has allowed us to perform the largest collaborative study ever reported, to investigate the correlation between the FBN1 genotype and the nature and severity of the clinical phenotype. A range of qualitative and quantitative clinical parameters (skeletal, cardiovascular, ophthalmologic, skin, pulmonary, and dural) was compared for different classes of mutation (types and locations) in 1,013 probands with a pathogenic FBN1 mutation. A higher probability of ectopia lentis was found for patients with a missense mutation substituting or producing a cysteine, when compared with other missense mutations. Patients with an FBN1 premature termination codon had a more severe skeletal and skin phenotype than did patients with an inframe mutation. Mutations in exons 24-32 were associated with a more severe and complete phenotype, including younger age at diagnosis of type I fibrillinopathy and higher probability of developing ectopia lentis, ascending aortic dilatation, aortic surgery, mitral valve abnormalities, scoliosis, and shorter survival; the majority of these results were replicated even when cases of neonatal MFS were excluded. These correlations, found between different mutation types and clinical manifestations, might be explained by different underlying genetic mechanisms (dominant negative versus haploinsufficiency) and by consideration of the two main physiological functions of fibrillin-1 (structural versus mediator of TGFβ signalling). Exon 24-32 mutations define a high-risk group for cardiac manifestations associated with severe prognosis at all ages.

Original languageEnglish (US)
Pages (from-to)454-466
Number of pages13
JournalAmerican Journal of Human Genetics
Volume81
Issue number3
DOIs
StatePublished - Sep 2007

Fingerprint

Marfan Syndrome
Phenotype
Mutation
Ectopia Lentis
Missense Mutation
Exons
Fibrillin-1
Haploinsufficiency
Skin
Nonsense Codon
Scoliosis
Mitral Valve
Age of Onset
Cysteine
Dilatation
Genotype
Databases
Lung
Survival

ASJC Scopus subject areas

  • Genetics

Cite this

Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations : An international study. / Faivre, L.; Collod-Beroud, G.; Loeys, B. L.; Child, A.; Binquet, C.; Gautier, E.; Callewaert, B.; Arbustini, E.; Mayer, K.; Arslan-Kirchner, M.; Kiotsekoglou, A.; Comeglio, P.; Marziliano, N.; Dietz, Harry C; Halliday, D.; Beroud, C.; Bonithon-Kopp, C.; Claustres, M.; Muti, C.; Plauchu, H.; Robinson, P. N.; Adès, L. C.; Biggin, A.; Benetts, B.; Brett, M.; Holman, K. J.; De Backer, J.; Coucke, P.; Francke, U.; De Paepe, A.; Jondeau, G.; Boileau, C.

In: American Journal of Human Genetics, Vol. 81, No. 3, 09.2007, p. 454-466.

Research output: Contribution to journalArticle

Faivre, L, Collod-Beroud, G, Loeys, BL, Child, A, Binquet, C, Gautier, E, Callewaert, B, Arbustini, E, Mayer, K, Arslan-Kirchner, M, Kiotsekoglou, A, Comeglio, P, Marziliano, N, Dietz, HC, Halliday, D, Beroud, C, Bonithon-Kopp, C, Claustres, M, Muti, C, Plauchu, H, Robinson, PN, Adès, LC, Biggin, A, Benetts, B, Brett, M, Holman, KJ, De Backer, J, Coucke, P, Francke, U, De Paepe, A, Jondeau, G & Boileau, C 2007, 'Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: An international study', American Journal of Human Genetics, vol. 81, no. 3, pp. 454-466. https://doi.org/10.1086/520125
Faivre, L. ; Collod-Beroud, G. ; Loeys, B. L. ; Child, A. ; Binquet, C. ; Gautier, E. ; Callewaert, B. ; Arbustini, E. ; Mayer, K. ; Arslan-Kirchner, M. ; Kiotsekoglou, A. ; Comeglio, P. ; Marziliano, N. ; Dietz, Harry C ; Halliday, D. ; Beroud, C. ; Bonithon-Kopp, C. ; Claustres, M. ; Muti, C. ; Plauchu, H. ; Robinson, P. N. ; Adès, L. C. ; Biggin, A. ; Benetts, B. ; Brett, M. ; Holman, K. J. ; De Backer, J. ; Coucke, P. ; Francke, U. ; De Paepe, A. ; Jondeau, G. ; Boileau, C. / Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations : An international study. In: American Journal of Human Genetics. 2007 ; Vol. 81, No. 3. pp. 454-466.
@article{12d8f954e1c44f1aa2e7c0987fdb27dd,
title = "Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: An international study",
abstract = "Mutations in the fibrillin-1 (FBN1) gene cause Marfan syndrome (MFS) and have been associated with a wide range of overlapping phenotypes. Clinical care is complicated by variable age at onset and the wide range of severity of aortic features. The factors that modulate phenotypical severity, both among and within families, remain to be determined. The availability of international FBN1 mutation Universal Mutation Database (UMD-FBN1) has allowed us to perform the largest collaborative study ever reported, to investigate the correlation between the FBN1 genotype and the nature and severity of the clinical phenotype. A range of qualitative and quantitative clinical parameters (skeletal, cardiovascular, ophthalmologic, skin, pulmonary, and dural) was compared for different classes of mutation (types and locations) in 1,013 probands with a pathogenic FBN1 mutation. A higher probability of ectopia lentis was found for patients with a missense mutation substituting or producing a cysteine, when compared with other missense mutations. Patients with an FBN1 premature termination codon had a more severe skeletal and skin phenotype than did patients with an inframe mutation. Mutations in exons 24-32 were associated with a more severe and complete phenotype, including younger age at diagnosis of type I fibrillinopathy and higher probability of developing ectopia lentis, ascending aortic dilatation, aortic surgery, mitral valve abnormalities, scoliosis, and shorter survival; the majority of these results were replicated even when cases of neonatal MFS were excluded. These correlations, found between different mutation types and clinical manifestations, might be explained by different underlying genetic mechanisms (dominant negative versus haploinsufficiency) and by consideration of the two main physiological functions of fibrillin-1 (structural versus mediator of TGFβ signalling). Exon 24-32 mutations define a high-risk group for cardiac manifestations associated with severe prognosis at all ages.",
author = "L. Faivre and G. Collod-Beroud and Loeys, {B. L.} and A. Child and C. Binquet and E. Gautier and B. Callewaert and E. Arbustini and K. Mayer and M. Arslan-Kirchner and A. Kiotsekoglou and P. Comeglio and N. Marziliano and Dietz, {Harry C} and D. Halliday and C. Beroud and C. Bonithon-Kopp and M. Claustres and C. Muti and H. Plauchu and Robinson, {P. N.} and Ad{\`e}s, {L. C.} and A. Biggin and B. Benetts and M. Brett and Holman, {K. J.} and {De Backer}, J. and P. Coucke and U. Francke and {De Paepe}, A. and G. Jondeau and C. Boileau",
year = "2007",
month = "9",
doi = "10.1086/520125",
language = "English (US)",
volume = "81",
pages = "454--466",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations

T2 - An international study

AU - Faivre, L.

AU - Collod-Beroud, G.

AU - Loeys, B. L.

AU - Child, A.

AU - Binquet, C.

AU - Gautier, E.

AU - Callewaert, B.

AU - Arbustini, E.

AU - Mayer, K.

AU - Arslan-Kirchner, M.

AU - Kiotsekoglou, A.

AU - Comeglio, P.

AU - Marziliano, N.

AU - Dietz, Harry C

AU - Halliday, D.

AU - Beroud, C.

AU - Bonithon-Kopp, C.

AU - Claustres, M.

AU - Muti, C.

AU - Plauchu, H.

AU - Robinson, P. N.

AU - Adès, L. C.

AU - Biggin, A.

AU - Benetts, B.

AU - Brett, M.

AU - Holman, K. J.

AU - De Backer, J.

AU - Coucke, P.

AU - Francke, U.

AU - De Paepe, A.

AU - Jondeau, G.

AU - Boileau, C.

PY - 2007/9

Y1 - 2007/9

N2 - Mutations in the fibrillin-1 (FBN1) gene cause Marfan syndrome (MFS) and have been associated with a wide range of overlapping phenotypes. Clinical care is complicated by variable age at onset and the wide range of severity of aortic features. The factors that modulate phenotypical severity, both among and within families, remain to be determined. The availability of international FBN1 mutation Universal Mutation Database (UMD-FBN1) has allowed us to perform the largest collaborative study ever reported, to investigate the correlation between the FBN1 genotype and the nature and severity of the clinical phenotype. A range of qualitative and quantitative clinical parameters (skeletal, cardiovascular, ophthalmologic, skin, pulmonary, and dural) was compared for different classes of mutation (types and locations) in 1,013 probands with a pathogenic FBN1 mutation. A higher probability of ectopia lentis was found for patients with a missense mutation substituting or producing a cysteine, when compared with other missense mutations. Patients with an FBN1 premature termination codon had a more severe skeletal and skin phenotype than did patients with an inframe mutation. Mutations in exons 24-32 were associated with a more severe and complete phenotype, including younger age at diagnosis of type I fibrillinopathy and higher probability of developing ectopia lentis, ascending aortic dilatation, aortic surgery, mitral valve abnormalities, scoliosis, and shorter survival; the majority of these results were replicated even when cases of neonatal MFS were excluded. These correlations, found between different mutation types and clinical manifestations, might be explained by different underlying genetic mechanisms (dominant negative versus haploinsufficiency) and by consideration of the two main physiological functions of fibrillin-1 (structural versus mediator of TGFβ signalling). Exon 24-32 mutations define a high-risk group for cardiac manifestations associated with severe prognosis at all ages.

AB - Mutations in the fibrillin-1 (FBN1) gene cause Marfan syndrome (MFS) and have been associated with a wide range of overlapping phenotypes. Clinical care is complicated by variable age at onset and the wide range of severity of aortic features. The factors that modulate phenotypical severity, both among and within families, remain to be determined. The availability of international FBN1 mutation Universal Mutation Database (UMD-FBN1) has allowed us to perform the largest collaborative study ever reported, to investigate the correlation between the FBN1 genotype and the nature and severity of the clinical phenotype. A range of qualitative and quantitative clinical parameters (skeletal, cardiovascular, ophthalmologic, skin, pulmonary, and dural) was compared for different classes of mutation (types and locations) in 1,013 probands with a pathogenic FBN1 mutation. A higher probability of ectopia lentis was found for patients with a missense mutation substituting or producing a cysteine, when compared with other missense mutations. Patients with an FBN1 premature termination codon had a more severe skeletal and skin phenotype than did patients with an inframe mutation. Mutations in exons 24-32 were associated with a more severe and complete phenotype, including younger age at diagnosis of type I fibrillinopathy and higher probability of developing ectopia lentis, ascending aortic dilatation, aortic surgery, mitral valve abnormalities, scoliosis, and shorter survival; the majority of these results were replicated even when cases of neonatal MFS were excluded. These correlations, found between different mutation types and clinical manifestations, might be explained by different underlying genetic mechanisms (dominant negative versus haploinsufficiency) and by consideration of the two main physiological functions of fibrillin-1 (structural versus mediator of TGFβ signalling). Exon 24-32 mutations define a high-risk group for cardiac manifestations associated with severe prognosis at all ages.

UR - http://www.scopus.com/inward/record.url?scp=34548232284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548232284&partnerID=8YFLogxK

U2 - 10.1086/520125

DO - 10.1086/520125

M3 - Article

VL - 81

SP - 454

EP - 466

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 3

ER -